Key result
Combining modified WHO 2.0 with CARPREG II offers the most robust pregnancy cardiovascular risk assessment.
Combining modified WHO 2.0 I-IV with CARPREG II offers the most robust maternal cardiovascular risk stratification, while highlighting the need for individualized, multidisciplinary care and specific tools for cancer survivors.
Answers are grounded in this paper and cite their sources.
Supports combined modified WHO 2.0 and CARPREG II for pregnancy risk stratification; leaves open cancer survivor-specific tools.
We sought to provide a brief review of available scores and factors to consider when assessing cardiovascular risk of pregnancy. We also discuss maternal cardiovascular risk stratification of survivors of childhood and adolescent cancer and congenital heart disease and identify gaps in knowledge. The modified WHO 2.0 I-IV in conjunction with the CARPREG II provides the most robust risk score to date but still has shortcomings. No score specifically addresses cardiovascular risk of pregnancy in survivors of cancer. While several tools for assessing risk exist, consideration of patient-specific factors also play an important role. Moderate and high-risk patients may be best cared for by multidisciplinary teams.
No takes yet. Share an insight, caveat, or question.
Crooks et al. (2026) conducted a review in Cardiovascular risk in pregnancy, including survivors of childhood/adolescent cancer and congenital heart disease. Modified WHO 2.0 I-IV and CARPREG II risk scores was evaluated on Maternal cardiovascular risk stratification. Modified WHO 2.0 I-IV combined with CARPREG II provides the most robust pregnancy cardiovascular risk assessment to date, though no score specifically addresses cancer survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: